Florida Senate - 2019 SB 1658 By Senator Simpson 10-01387A-19 20191658__ 1 A bill to be entitled 2 An act relating to the Statewide Task Force on Opioid 3 Drug Abuse; creating s. 381.888, F.S.; creating the 4 Statewide Task Force on Opioid Drug Abuse for a 5 specified purpose; providing for the membership of the 6 task force; providing for reimbursement of per diem 7 and travel expenses for members; requiring the 8 Department of Legal Affairs to provide the task force 9 with necessary staff; requiring the task force to hold 10 an organizational session before a specified date and 11 quarterly meetings thereafter; authorizing the chair 12 to call for additional meetings in extraordinary 13 circumstances; specifying duties of the task force; 14 requiring the task force to submit reports to the 15 Legislature by specified dates; providing an effective 16 date. 17 18 Be It Enacted by the Legislature of the State of Florida: 19 20 Section 1. Section 381.888, Florida Statutes, is created to 21 read: 22 381.888 Statewide Task Force on Opioid Drug Abuse.— 23 (1)(a) There is created adjunct to the Department of Legal 24 Affairs the Statewide Task Force on Opioid Drug Abuse, a task 25 force as defined in s. 20.03. The task force is created for the 26 purpose of researching opioid drug abuse, evaluating effective 27 strategies for education, interdiction, arrest, prosecution, 28 treatment and prevention, and providing policy recommendations 29 to the Legislature. 30 (b) The task force shall consist of the following members, 31 or their designees: 32 1. One representative appointed by the Attorney General, 33 who shall serve as chair. 34 2. One representative appointed by the Surgeon General, who 35 shall serve as vice chair. 36 3. One representative appointed by the Commissioner of 37 Education. 38 4. One representative appointed by the Commissioner of the 39 Florida Department of Law Enforcement. 40 5. One representative appointed by the Secretary of 41 Children and Family Services. 42 6. One representative appointed by the Secretary of Health 43 Care Administration. 44 7. One representative appointed by the Secretary of 45 Corrections. 46 8. One representative appointed by the Secretary of 47 Juvenile Justice. 48 9. One representative appointed by the President of the 49 Senate. 50 10. One representative appointed by the Speaker of the 51 House of Representatives. 52 11. Two sheriffs appointed by the Attorney General. 53 12. Two police chiefs appointed by the Attorney General. 54 13. Two state attorneys appointed by the Attorney General. 55 14. Two public defenders appointed by the Attorney General. 56 15. One representative appointed by the State Courts 57 Administrator. 58 16. Three representatives from addiction and recovery 59 associations appointed by the Attorney General, each from 60 different geographic areas of the state. 61 17. One representative of the Florida Medical Association. 62 18. One representative of the Florida Pharmacy Association. 63 19. One representative of the insurance industry appointed 64 by the Insurance Commissioner. 65 (c) Members of the task force are entitled to receive 66 reimbursement for per diem and travel expenses in accordance 67 with s. 112.061. 68 (d) The Department of Legal Affairs shall provide the task 69 force with staff necessary to assist the task force in the 70 performance of its duties. 71 (2) The task force shall hold an organizational session by 72 July 15, 2019. Thereafter, the task force shall meet at least 73 four times per year. Additional meetings may be held if the 74 chair determines that extraordinary circumstances require an 75 additional meeting. A majority of the members of the task force 76 constitutes a quorum. 77 (3) The task force shall do all of the following: 78 (a) Collect and organize data concerning the nature and 79 extent of opioid drug abuse in this state, including, but not 80 limited to, the overdose death rate, neonatal abstinence 81 syndrome statistics, the Florida Youth Substance Abuse Survey, 82 Automated Reports and Consolidated Ordering System data, and 83 United States Drug Enforcement Administration seizure data for 84 opioids, including fentanyl and synthetic fentanyl. 85 (b) Collect and organize data concerning the current costs 86 to state and local governments associated with the interdiction, 87 prosecution, incarceration, education, monitoring, and treatment 88 of opioid abuse and misuse in this state. 89 (c) Identify available federal, state, and local programs 90 that provide services to combat opioid drug abuse. 91 (d) Identify and evaluate best practices for the treatment 92 of opioid drug abuse. 93 (e) Identify and evaluate the sources of opioids being 94 abused and misused and causes of opioid drug abuse. 95 (f) Identify whether there is any need for additional 96 regulatory activity, including scheduling or emergency 97 scheduling, of synthetic opioid derivatives including synthetic 98 fentanyl derivatives. 99 (g) Identify and evaluate ways to reduce the demand for 100 opioids, including, but not limited to, alternative pain 101 management that does not involve the use of opioids. 102 (h) Identify and evaluate ways to reduce the availability 103 of opioids to opioid drug abusers, including increased 104 monitoring, expanded interdiction, and cooperation among law 105 enforcement agencies at all levels. 106 (i) Identify and evaluate training and resources needed by 107 law enforcement officers to deal with users and addicts of 108 opioid drugs. 109 (j) Identify and evaluate best practices for law 110 enforcement encounters with arrestees and others suffering from 111 opioid addiction. 112 (k) Identify and evaluate best practices for treating 113 arrestees in custody suffering from opioid addiction. 114 (l) Identify and evaluate alternatives to conviction or 115 incarceration for arrestees suffering from opioid addiction. 116 (m) Identify and evaluate programs and protocols for 117 consideration and use with inmates suffering from opioid 118 addiction. 119 (n) Identify and evaluate programs for dealing with minors 120 suffering from opioid drug abuse and addiction. 121 (o) Identify and evaluate educational programs for 122 children, young adults, and adults on the dangers of opioid 123 abuse and misuse. 124 (p) Evaluate methods to increase public awareness of the 125 dangers of opioid abuse and misuse. 126 (q) Develop a list of projects and priorities to be funded 127 by the Legislature or from other sources, including the proceeds 128 arising from any judgments or settlements with opioid 129 manufacturers, distributors, or others related to opioid drug 130 abuse. 131 (4) At the chair’s direction, the task force may break into 132 subcommittees or small groups that must present their findings 133 to the task force as a whole. 134 (5) The task force shall submit interim reports to the 135 President of the Senate and the Speaker of the House of 136 Representatives by December 1, 2020, and January 15, 2021, and 137 shall submit a final report of its recommendations to the 138 President of the Senate and the Speaker of the House of 139 Representatives by December 1, 2022. 140 Section 2. This act shall take effect upon becoming a law.